LBRX – lb pharmaceuticals inc (US:NASDAQ)
Stock Stats
News
LB Pharmaceuticals (NASDAQ:LBRX) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
LB Pharmaceuticals (NASDAQ:LBRX) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
LB Pharmaceuticals (NASDAQ:LBRX) had its price target raised by analysts at Stifel Nicolaus from $27.00 to $35.00. They now have a "buy" rating on the stock.
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Form 4 LB PHARMACEUTICALS INC For: Dec 10 Filed by: Pai Panandiker Kaya Kamlesh
Form 3 LB PHARMACEUTICALS INC For: Nov 10 Filed by: Pai Panandiker Kaya Kamlesh
Form 8-K LB PHARMACEUTICALS INC For: Nov 10
Form 8-K LB PHARMACEUTICALS INC For: Nov 12
Form 10-Q LB PHARMACEUTICALS INC For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.